Publication | Closed Access

Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial

Diabetes ManagementInsulin ManagementDiabetesChronic Kidney DiseasePharmacologyType 2Diabetic Kidney DiseasePharmacotherapyDiabetes MellitusMedicineAntidiabetes Treatment